Enzo Biochem explains $4.6M loss

Enzo BioChem Inc., Manhattan, biochemical research and development

Quarter: Ended April 30, 2010

Net income: Loss of $4.6 million compared with loss of $4.2 million in the same quarter last year.

Net revenue: $23.8 million compared with $23 million in the year-ago quarter.

Company statement: The company, which has a major division, Enzo Clinical Labs, based in Farmingdale, said selling, general and administrative expenses rose at its life sciences business because it is integrating a new business and changing its product lineup. Also, its clinical lab business spent more on hiring and invested in new tests. - Joseph Mallia